| Prev Close | 45.46 |
| Open | 45.98 |
| Day Low/High | 45.67 / 46.21 |
| 52 Wk Low/High | 30.89 / 47.98 |
| Volume | 2.39M |
| Avg Volume | 1.86M |
| Exchange | NYSE |
| Shares Outstanding | 2.55B |
| Market Cap | 115.21B |
| EPS | 2.00 |
| Div & Yield | 0.95 (2.10%) |
Latest News
Novo Nordisk Shares Leap Higher After Solid Earnings and Full-Year Sales Upgrade
World's biggest diabetes drugmaker sees lower 2018 prices in U.S. markets
Novo Nordisk And Glooko Advance Their Digital Health Collaboration With Launch Of Unique Integrated App For Improved Diabetes Management
Novo Nordisk makes the app available for free
Nevada Senate Passes Bill to Force Diabetes Drug Manufacturers to Disclose Pricing Practices
The legislation would also force companies to announce planned price hikes.
Dow Holds Lower After House Passes Health Care Vote, Crude Falls
Stocks move mostly lower on Thursday after the House passes a bill to repeal and replace the Affordable Care Act.
Ratings Changes Today
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ANH, DVN, EXEL, FMC, FSI, GLT, MEOH, MJCO, MOH, NVO, RPXC, TECH, WU, WWE Downgrades: CIGI, IPHI, QUOT Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
Novo Nordisk Launches Xultophy® 100/3.6 (insulin Degludec And Liraglutide Injection) In The United States
- New combination treatment option for adults with type 2 diabetes now available in pharmacies
5 Things You Must Know Before the Market Opens Wednesday
U.S. stock futures decline and European shares trade lower following disappointing earnings from Apple and as Wall Street looks to Wednesday's announcement from the Federal Reserve on interest rates.
